The Application Notebook
Recent technological advances in macromolecular crystallography led to focus on the study of more and more sophisticated biological systems, such as protein–protein complexes. Nevertheless, they represent one of the most challenging areas in modern structural biology.
Wyatt Technology Corporation, Santa Barbara, California, USA.
Recent technological advances in macromolecular crystallography led to focus on the study of more and more sophisticated biological systems, such as protein–protein complexes. Nevertheless, they represent one of the most challenging areas in modern structural biology.
Baseplates are large multi-protein assemblies found at the tip of bacteriophage tails, which constitute key components during host infection. In Gram-positive bacteria, infection is initiated by binding of the phage receptor binding protein (RBP, BppL trimer) to a saccharidic receptor on the host surface. Several RBPs are present in each baseplate. A detailed analysis of these complexes would result in a better understanding of the mechanisms underlying phage–host interaction.
We report here a method to characterize protein–protein interactions and stoichiometry in Mega-Dalton macromolecular assemblies as illustrated by the study of the TP901-1 lactococcal phage baseplate. Our set-up involves the combined measurements from MALS, QELS, refractometry and UV280 nm absorbance coupled on-line with an analytical SEC.
First, we confirmed that BppL is homotrimeric in solution, as observed in the crystal structure. Then, operon co-expression of BppU and BppL proteins resulted in a complex containing 9 BppL and 3 BppU copies (Figure 1).
Figure 1
Then, co-expressing BppL, BppU and Dit proteins in the same way yielded a 1.7 MDa complex constituted by 54 BppL, 18 BppU and 6 Dit copies (Figure 2) and characterized by Rh and Rg values of 12.5 nm and 11.4 nm, respectively.
Figure 2
These data provided a picture of how these proteins assemble to form a baseplate and that 54 host binding sites are displayed by this phage suggesting that avidity contribute to host anchoring.
The reported method illustrates the characterization of giant macromolecular complexes providing their size and stoichiometry in solution. When studying such high molecular-weight protein complexes (Rg > 8 nm), the Rg becomes accessible, in contrast to normal-size proteins. We describe here the biggest macromolecular entity, to our knowledge, characterized to date using this approach.
This note graciously submitted by David Veesler, Architecture et Fonction des Macromolécules Biologiques, Unité Mixte de Recherches UMR6098, CNRS,Université de Provence Université de la Méditerranée, Marseille, France.
Wyatt Technology Corporation
6300 Hollister Avenue, Santa Barbara, California 93117, USA
tel. +1 805 681 9009 fax +1 805 681 0123
Website: www.wyatt.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.